Vectus Biosystems Limited (ASX:VBS)
Australia · Delayed Price · Currency is AUD 0.2100
+0.0100 (5.00%)
Jul 15, 2026, 12:30 PM AEST
Vectus Biosystems Market Cap
Vectus Biosystems has a market cap or net worth of 12.3 million as of July 14, 2026. Its market cap has decreased by -17.45% in one year.
Market Cap
12.30M
Enterprise Value
12.44M
Revenue
89.96K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.21
Market Cap Chart
Since February 23, 2016, Vectus Biosystems's market cap has decreased from 36.22M to 12.30M, a decrease of -66.05%. That is a compound annual growth rate of -9.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 10.76M | 11.89% |
| Dec 31, 2025 | 9.62M | 134.56% |
| Dec 23, 2024 | 4.10M | -74.31% |
| Dec 29, 2023 | 15.96M | -58.89% |
| Dec 30, 2022 | 38.83M | -15.39% |
| Dec 31, 2021 | 45.89M | 20.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Argenica Therapeutics | 16.06M |
| Immuron | 14.05M |
| ReNerve | 13.78M |
| AdAlta | 11.90M |
| Cambium Bio | 11.07M |
| Invex Therapeutics | 7.89M |
| Tissue Repair | 6.65M |
| Bio-Gene Technology | 6.56M |